Association of cyclin-dependent kinase inhibitor 2A/B with increased risk of developing breast cancer.
Seifi S, Pouya F, Rahmani M, Mehramiz M, Rastgar-Moghadam A, Gharib M, Rahmani F, Shahidsales S, Hassanian SM, Khazaei M, Dadjoo P, Parvin SS, Yazdinezhad Y, Parizadeh SMR, Ferns GA, Fathi M, Avan A.
Seifi S, et al.
J Cell Physiol. 2020 Jun;235(6):5141-5145. doi: 10.1002/jcp.29388. Epub 2019 Nov 12.
J Cell Physiol. 2020.
PMID: 31721206